Back to Journals » Neuropsychiatric Disease and Treatment » Volume 9

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US

Total article views   HTML views PDF downloads Totals
13,400 Dovepress* 12,121+ 1,498 13,619
PubMed Central* 1,279 424 1,703
Totals 13,400 1,922 15,322
*Since 10 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar